These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8331925)
1. Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice. McNamara MJ; Norton JA; Nauta RJ; Alexander HR J Surg Res; 1993 Apr; 54(4):316-21. PubMed ID: 8331925 [TBL] [Abstract][Full Text] [Related]
2. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Pallua N; Low JF; von Heimburg D Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624 [TBL] [Abstract][Full Text] [Related]
5. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800 [TBL] [Abstract][Full Text] [Related]
6. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Brouckaert P; Everaerdt B; Fiers W Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365 [TBL] [Abstract][Full Text] [Related]
7. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality. Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model. Pallua N; von Heimburg D Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623 [TBL] [Abstract][Full Text] [Related]
10. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898 [TBL] [Abstract][Full Text] [Related]
13. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Probert L; Plows D; Kontogeorgos G; Kollias G Eur J Immunol; 1995 Jun; 25(6):1794-7. PubMed ID: 7615010 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice. Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438 [TBL] [Abstract][Full Text] [Related]
15. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation. Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792 [TBL] [Abstract][Full Text] [Related]
16. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432. Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639 [TBL] [Abstract][Full Text] [Related]
17. [Changes of circulating Lps and cytokines in burned patients after anti-endotoxin therapy]. Fu W; Xiao G; Yu P Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):355-8. PubMed ID: 9206199 [TBL] [Abstract][Full Text] [Related]
18. Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin. Zimecki M; Chodaczek G; Kocieba M; Kruzel ML FEMS Immunol Med Microbiol; 2004 Oct; 42(2):167-72. PubMed ID: 15364100 [TBL] [Abstract][Full Text] [Related]
19. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermia induces IL-1 alpha but does not decrease release of IL-1 alpha or TNF-alpha after endotoxin. Blake D; Bessey P; Karl I; Nunnally I; Hotchkiss R Lymphokine Cytokine Res; 1994 Oct; 13(5):271-5. PubMed ID: 7858059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]